MariMed to Host Second Quarter 2021 Investor Conference Call On Tuesday, August 17, 2021 at 8:00 a.m. ET

Download as PDF

NORWOOD, Mass., July 28, 2021 /CNW/ - MariMed Inc. (OTCQX: MRMD) (the "Company" or "MariMed"), a leading multi-state cannabis operator focused on health and wellness, today announced it will hold a conference call on Tuesday, August 17, 2021 at 8:00 a.m. ET to discuss its results for the second quarter ended June 30, 2021.

CONFERENCE CALL DETAILS

DATE:                                     

Tuesday, August 17, 2021

TIME:                                      

8:00 a.m. Eastern Time

WEBCAST:                              

Click to Access

DIAL-IN NUMBER:                 

1 (888) 664-6383

CONFERENCE ID:                   

96689386

REPLAY:                                  

(416) 764-8677 or (888) 390-0541
Encore Replay Code: 689386#
Available until 12:00 midnight ET on Tuesday, August 31, 2021

To learn more about MariMed or to join the Company's email distribution list, please visit www.marimedinc.com.

About MariMed

MariMed Inc., a multi-state cannabis operator, is dedicated to improving the health and wellness of people using cannabinoids and cannabis products. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units, keeping it at the forefront of cannabis science and innovation. Proprietary formulations created by the Company's technicians are embedded in its industry-leading products and brands, including Betty's Eddies®, Nature's Heritage™, Bourne Baking Co., and Kalm Fusion®. For additional information, visit marimedinc.com.

Important Caution Regarding Forward-Looking Statements

This release contains certain forward-looking statements and information relating to MariMed Inc. that is based on the beliefs of MariMed Inc.'s management, as well as assumptions made by and information currently available to the Company. Such statements reflect the current views of the Company with respect to future events, including estimates and projections of revenue and EBITDA and about its business based on certain assumptions of its management, including those described in this release. These statements are not guaranteeing of future performance and involve risk and uncertainties that are difficult to predict, including, among other factors, changes in demand for the Company's services and products, changes in the law and its enforcement, and changes in the economic environment. Additional risk factors are included in the Company's public filings with the SEC. Should one or more of these underlying assumptions prove incorrect, actual results may vary materially from those described herein as "hoped," "anticipated," "believed," "planned, "estimated," "preparing," "potential," "expected," "looks" or words of a similar nature. The Company does not intend to update these forward-looking statements. None of the content of any of the websites referred to herein (even if a link is provided for your convenience) is incorporated into this release and the Company assumes no responsibility for any of such content.

All trademarks and service marks are the property of their respective owners.

SOURCE MariMed Inc.

Released July 28, 2021